MIAMI, Dec. 17, 2020 (World NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader of electronic therapeutics offering evidence-centered therapeutic interventions to sufferers, announces that Ben Kaplan, President, Main Government Officer and Chairman, has issued a letter to Ehave’s stockholders. The complete textual content is as follows:
To My Fellow Stockholders,
About the course of 2020, Ehave, Inc. has produced substantial development in advancing our strategic plan and strike several milestones in our journey. From a company standpoint, we are a thoroughly reporting company with the SEC. We have utilized for OTCQB registration and anticipate filing with the Canadian Securities Exchange by the conclude of the yr. The combined endeavours of our administration staff, Board of Directors, and healthcare advisory board has resulted in numerous achievements which includes the adhering to highlights:
Ehave expanded its psychedelic psychological wellness system to far better provide researchers and clinicians, even though also permitting patients to take more management around their psychedelic clinical documents. The Ehave Dashboard is a knowledge driven platform that has been strategically formulated to provide superior interaction amid health-related practitioners and health care vendors. The aggregation of data and information into just one software has confirmed successful in streamlining the wellbeing procedure for the two sufferers and suppliers. The cloud based mostly system can produce important characteristics and abilities to health care suppliers, all even though enabling seamless integrations with almost everything from digital well being information (EHRs) to telehealth providers to psychedelic researchers and clinicians. The Ehave Dashboard has been formulated by means of several years of tests with mental healthcare pros at one of Canada’s biggest hospitals. In addition to giving superior results, the proprietary system allows people today to take manage of their actual physical and psychological wellbeing. 2020 marked a to start with for our Enterprise as our information platform permitted sufferers to obtain innovative therapies to psychological health by offering clinicians and pharmaceutical corporations with knowledge that will make the provision of treatment far more easily out there.
Ehave will make use of its Dashboard and digital technologies to help psychedelic medicine corporations in the creation of the new paradigm in how mental health is addressed. Ehave target patients, physicians, and scientists to aid them speedily authenticate or launch own, verified information and give extra regulate in scenarios where rely on simply cannot be compromised. By using blockchain know-how, Ehave can offer its health care associates an option to lessen their administration prices by up to 90%.
Our primary aim is, and often has been, improving upon psychological health and fitness and combatting mental ailment. Practically one particular in 5 (19 %) U.S. grownups experience some type of mental sickness and one grownup in 24 (4.1 p.c) has a critical psychological sickness. Psychological health issues is treatable and our mission is to take care of even all those with critical mental ailment. Throughout the U.S. economy, critical mental sickness brings about $193.2 billion in lost earnings each and every year, whilst melancholy and anxiousness diseases price tag the international financial state $1 trillion in lost efficiency every single 12 months. Suicide is the 10th foremost bring about of dying in the U.S. and 90% of individuals who died by suicide had proven signs and symptoms of a mental wellbeing problem, according to interviews with spouse and children, buddies and healthcare industry experts. When you make strides in aiding individuals with mental overall health, you get observed. We have been continuously having protection all over the technologies and partnerships we are developing.
Mycotopia Treatment. Mycotopia Therapy is a wholly-owned subsidiary of Ehave that delivers a new paradigm for psychological wellness. Our primary goal by means of Mycotopia Therapy is to provide a human practical experience of creating a roadmap of optimal mind-system-spirit health and fitness. Our physicians and practitioners are disrupting the landscape by offering certainty on what is taking place and what to do about it. Mycotopia Remedy has reworked into an ecosystem to nurture the progress of therapies employing psychedelics. Ehave, by way of its Mycotopia Remedy subsidiary, owns 10% of the organization that makes the PsyTech Psychedelic Market Digital investor Conferences and not long ago announced ideas to offer psychedelic retreats. The psilocybin-guided wellness retreats will be provided in several locations all over the world, and will be supervised by certified health-related industry experts in a harmless, lawful, and at ease setting. These retreats will be in conjunction with our husband or wife facilities.
In January, 2020 Ehave announced the obtain of a 10 p.c stake in Psychedelitech, Inc. by way of the Mycotopia Treatment subsidiary. Psychedelitech is the mum or dad firm of PsyTech, the world’s most acknowledged psychedelic meeting. As a final result of a new economic transaction, Psychedelitech is valued at $15 million, building Ehave’s expenditure value $1.5 million. Speakers at the PsyTech Virtual Trader Conferences have integrated Person Lieberman, Director of Nahana Foundation Liana Gillooly, Founder/Development Officer at North Star/MAPS David Nikzad, Founder of Orthogonal Thinker Inc./Ei.Ventures Stacey Wallin, Co-Founder and Chief Approach Officer at Numinus Wellness, Inc. Rick Doblin, Ph.D., Founder and Executive Director of the Multidisciplinary Affiliation for Psychedelic Reports (MAPS) Todd Shapiro of Purple Light Holland Matthew Johnson, PhD., Professor of Psychiatry and Actions at Johns Hopkins Christian Angermayer, Founder of ATAI Life Sciences Dr. Rosalid Watts, Scientific Psychologist at the Psychedelic Research Group at Imperial College London Bruce Linton, Founder, and Previous Chairman and Co-CEO of Cover Advancement Company and Dr. Mark Braunstein, The Hashish Psychiatrist and PsyTech Healthcare Advisor.
Partnership with Id Crucial. Ehave not too long ago declared it would be offering blockchain centered identity verification computer software for the health care group as a plug-in on its Dashboard. Adopting blockchain technological innovation to Ehave’s Dashboard has the potential to completely transform overall health care, putting the affected person at the middle of the health treatment ecosystem and expanding the stability, privacy, and interoperability of wellbeing data. Blockchain engineering is creating big chances for individuals, doctors, and researchers to accessibility information in new strategies with audit trails and verifiable authentication. On-line ID verification is seeing a spike in need pushed by the recent pandemic as numerous professional medical experts mail their employees to perform remotely. During the pandemic there has been a strong surge in demand for videoconferencing conversation in between patients, suppliers, experts, and other professional medical specialists. Healthcare documents and affected person details are nonetheless essential by legislation to be secure. Patient identification and verification is a single of the most difficult difficulties the healthcare sector faces through these turbulent situations, but it is important in imparting speedy and successful health care solutions to people. Ehave can offer a secure blockchain alternative to psychedelic clinicians and researchers, as nicely as other health-related experts.
With a renewed investigate interest in LSD, MDMA, Ketamine, and Psilocybin, and a developing normalization following decades of stigma, psychedelics are rapidly getting to be the future therapeutic frontier. Ehave just lately announced the formation of KetaDASH an Intravenous (IV) primarily based, dwelling supply system for clients who have been prescribed Ketamine. Ehave purchased the tangible and intangible property of CureDash, which currently operates an IV shipping and delivery system that will come to be the spine of KetaDash. By furnishing the platform for clinical practitioners to administer Ketamine intravenously to sufferers at household, we believe that numerous extra clients will get the therapy they involve. Ketamine is at present utilised to assist ease suffering and lets sedatives to be productive at reduced doses, lessening the total of likely addictive pain medicine required following specific healthcare strategies. Ketamine is now getting examined as a therapy for big melancholy, although it has not nevertheless been authorized by the Fda to treat despair. The KetaDASH system will include things like software program, staffing, protocols, and machines. Ehave has developed a smart and intuitive dashboard for KetaDash from in which the clients and the related nurses can get in-depth insight on how the Ketamine therapy is doing work. People will be in a position to generate a profile, verify availability of administering nurses, and plan appointments. People today are shelling out more time at house and home shipping and delivery has become more well-known.
Ketamine was originally accepted by the US Meals and Drug Administration (Fda) in 1970 as an anesthetic agent that was administered intravenously or intramuscularly for use in diagnostic and surgical processes. It is now readily available generically. Ketamine is now staying analyzed as a procedure for major melancholy, nevertheless it has not yet been accredited by the Food and drug administration to deal with depression. Esketamine (Spravato, Janssen) was authorised by the Fda past year for treatment method-resistant melancholy. Esketamine is a medicine utilised as a normal anesthetic and for treatment-resistant despair. Esketamine is applied as a nasal spray or by injection into a vein. Esketamine acts largely as a non-aggressive N-methyl-D-aspartate receptor antagonist. Numerous professional medical pros think Ketamine may have a one of a kind probable notably for most cancers-connected melancholy.
Addition of Vital Staff. While Ehave has a somewhat flat organizational construction, we usually have a need to have for robust management and a well-capable Board. 2020 marked the addition of a number of people today joining the Firm.
Alfred Farrington II joined our organization as the Chief Information and facts Officer. Mr. Harrington’s most important focus is investigation and enhancement of large-functionality technological know-how products and devices for collecting, examining, and processing effectiveness data to provide efficient remedies to age-previous complications.
Dr. Nithin Krishna, M.D., a neuroscience researcher, joined Ehave’s Clinical Advisory Board. As a member of the Company’s Professional medical Advisory Board, Dr. Krishna’s primary obligations will be to help and advise the Organization on human trials for its cognitive and psychedelic opportunities.
Victor S. Dorodny, MD, PhD, MPH joined our Advisory Board and will advise Ehave on HIPAA compliance and telemedicine engineering. Dr. Dorodny was one of the creators of the Wellness Insurance Portability and Accountability Act of 1996 (HIPAA). He has served on the Advisory Board of the Affiliation of Health-related Director of Details Programs and is the Past President of the Western Division of the National Association of Managed Treatment Physicians. Dr. Dorodny has served in an govt potential of various providers in which he has held the title of Main Medical Facts Officer, Main Scientific Advisor, and Main Health care Officer.
Russell Schachar, MD, FRCP(C) joined Ehave as Main Healthcare Officer. Dr. Schachar is a working towards baby and adolescent psychiatrist, Professor in the Department of Psychiatry at the University of Toronto, and Senior Scientist in the Analysis Institute at the Hospital for Sick Youngsters in Toronto, Canada where he retains the TD Bank Chair in Boy or girl and Adolescent Psychiatry and heads a cognitive neurosciences laboratory which focuses on psychiatric issues of childhood and adolescence.
Dr. Manideep Reddy (MD,MBA) is a answer concentrated physician and health care expert experienced in performing with shopper, authorities and enterprise dealing with initiatives. His recent engagements include things like environment up a Molecular genetics venture, telemedicine infrastructure for healthcare facility chain in Singapore and Malaysian sector, compliance and distribution infrastructure for neuroscience medications, molecular commercialization exit pathways for its generic molecules in cardiopulmonary and rheumatological disorders, and the agreement production facilities throughout 5 spots in India to manufacture the generic molecules for immunological and dermatological conditions.
As I outlined, we are delighted with our development to date and are quite psyched about our momentum and Ehave’s potential prospective customers. I would like to thank our workers, partners, and Advisory Board for their superb efforts and motivation, and our investors for their continued aid. We look ahead to a potent 2021.
Supplemental Ehave Inc. Information and facts
We are genuinely grateful for the help of EHVVF shareholders! Be sure to sign up for the discussion on our Ehave supporter’s telegram group at https://t.me/EhaveInc.
The business diligently posts crucial info and updates as a result of weekly videos from the official enterprise YouTube channel https://www.youtube.com/channel/UCnyW1mgMd0qmYkEMq3O6FWA.
Make sure you adhere to Ehave on Twitter @Ehaveinc1
About Ehave, Inc.
Ehave, Inc. (EHVVF) is a leader of electronic therapeutics providing proof-dependent therapeutic interventions to sufferers. Our key target is on enhancing the conventional treatment in therapeutics to avert or address mind conditions or disorders by means of the use of electronic therapeutics, independently or with each other, with medicines, equipment, and other therapies to improve individual treatment and health and fitness results. Our most important merchandise is the Ehave Telemetry Portal, which is a mental health informatics system that enables clinicians to make goal and intelligent decisions by info insights. The Ehave Infinity Portal features a impressive machine discovering and artificial intelligence platform with a developing set of innovative resources and apps produced by Ehave and its primary partners. This empowers clients, healthcare providers, and payers to address a broad variety of conditions as a result of superior excellent, safe and sound, and effective knowledge-driven involvement with smart and available equipment. For much more information pay a visit to: www.ehave.com.
Forward-Searching Assertion Disclaimer
This push release has “forward-searching statements” within the which means of the Personal Securities Litigation Reform Act of 1995. This sort of statements could be preceded by the phrases “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or very similar words and phrases. Forward-seeking statements are based on sure assumptions and are subject to several acknowledged and unfamiliar challenges and uncertainties, quite a few of which are outside of the Company’s regulate, and are unable to be predicted or quantified and as a result, actual benefits could differ materially from these expressed or implied by these types of ahead-hunting statements: (i) the initiation, timing, progress and results of the Company’s study, production and other enhancement efforts (ii) the Company’s means to progress its products to productively comprehensive enhancement and commercialization (iii) the production, progress, commercialization, and current market acceptance of the Company’s products (iv) the lack of sufficient funding to finance the item growth and business enterprise functions (v) aggressive providers and technologies within just the Company’s field and introduction of competing solutions (vi) the Company’s capability to create and manage corporate collaborations (vii) decline of critical management personnel (viii) the scope of safety the Organization is ready to establish and preserve for mental house legal rights masking its products and its skill to run its business without infringing the mental house legal rights of other individuals (ix) potential failure to comply with relevant health and fitness data privacy and stability rules and other condition and federal privacy and stability guidelines and (x) the issues of predicting actions of the United states Fda and its regulations. All ahead-searching statements bundled in this push release are made only as of the day of this push launch. The Company assumes no obligation to update any created or oral forward-looking assertion except required by law. A lot more in-depth details about the Organization and the danger things that may well have an effect on the realization of forward-wanting statements is contained beneath the heading “Chance Things” in Ehave, Inc.’s Registration Assertion on Sort F-1 filed with the Securities and Trade Commission (SEC) on September 24, 2015, as amended, which is available on the SEC’s web-site, https://www.sec.gov.
For Investor Relations, make sure you make contact with:
Cellphone: (623) 261-9046
Email: [email protected]